- Home
- PROV vs APLT Comparison
PROV vs APLT Comparison
Compare PROV & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- APLT
- Stock Information
- Founded
- PROV 1956
- APLT 2016
- Country
- PROV United States
- APLT United States
- Employees
- PROV N/A
- APLT N/A
- Industry
- PROV Savings Institutions
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- PROV Finance
- APLT Health Care
- Exchange
- PROV Nasdaq
- APLT Nasdaq
- Market Cap
- PROV 109.1M
- APLT 128.0M
- IPO Year
- PROV 1996
- APLT 2019
- Fundamental
- Price
- PROV $15.91
- APLT $0.85
- Analyst Decision
- PROV Hold
- APLT Buy
- Analyst Count
- PROV 1
- APLT 7
- Target Price
- PROV $16.00
- APLT $6.10
- AVG Volume (30 Days)
- PROV 8.3K
- APLT 12.0M
- Earning Date
- PROV 01-27-2025
- APLT 11-07-2024
- Dividend Yield
- PROV 3.52%
- APLT N/A
- EPS Growth
- PROV N/A
- APLT N/A
- EPS
- PROV 1.09
- APLT N/A
- Revenue
- PROV $39,794,000.00
- APLT N/A
- Revenue This Year
- PROV N/A
- APLT N/A
- Revenue Next Year
- PROV $11.75
- APLT $2,664.24
- P/E Ratio
- PROV $14.66
- APLT N/A
- Revenue Growth
- PROV N/A
- APLT N/A
- 52 Week Low
- PROV $12.01
- APLT $0.77
- 52 Week High
- PROV $16.70
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- PROV 44.41
- APLT 17.32
- Support Level
- PROV $16.30
- APLT $0.77
- Resistance Level
- PROV $16.37
- APLT $0.90
- Average True Range (ATR)
- PROV 0.24
- APLT 0.12
- MACD
- PROV -0.07
- APLT 0.20
- Stochastic Oscillator
- PROV 21.00
- APLT 12.81
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.